and not fully reversible airflow limitation. A cornerstone of COPD management is preventing acute exacerbations of COPD that becomes more frequent and severe as the disease progresses, and breaking the cycle of recurrence.
Self-management has been highlighted as a potential approach that has yielded clear association with reducing the risk of acute exacerbations of COPD. Action plans offer a form of self-management to help individuals recognize and initiate early treatment for exacerbations, thereby reducing their impact. However, despite the existing clinical practice guidelines for COPD, there is little consensus on an action plan for selfmanagement of COPD patients. This study was aimed to identify components of an action plan for self-management of COPD patients in the real clinical setting in South Korea.
Methods: This methodological study was conducted by the following steps: constructing the preliminary draft of an action plan from extensive literature reviews and existing clinical guidelines and recommendation regarding action plan and self-management for COPD patients; one-round Delphi method to find consensus within a group of 15 experts and 15 patients on the draft; testing content validity with 15 experts.
Results: Five components were included in the finalized action plan for self-management in COPD patients based on clinicians and patients input: (1) 10 questionnaires for self-monitoring of alteration in conditions 2) self-checking of body-temperature, pulse rate, and PEFR; (3) information on appropriate use of medications and changing medication when need that is tailored to an individual patient; (4) indications to visit a doctor/ emergency room; (5) information for family/primary care givers.
Conclusion:
Further studies are warranted to explore alignment with clinical practice guidelines and feasibility of adaptations, to facilitate wide applicability, and evaluation of the effectiveness of the action plan identified in this study. Results: 452 subjects completed all the visit, of which 88 subjects were excluded because of baseline FEV1/FEV6<70% or FEV1<80%pred.
364 subjects were included in the final analysis, of which 37 subjects developed COPD during following up. COPD group had older age (6 AE .8 vs 5 AE .6), higher ratio of smoking history (35% vs 21%) , higher ratio of rapid decline in FEV1 (64% vs 46%), lower baseline FEV1/FVC (0.7 AE .07 vs 0.8 AE .06) than non-COPD group. There were no differences in chronic respiratory symptoms, income class, educational level, comorbidity (hypertension, OSA), baseline level of SP-D, baseline FEV1%pred, family history, occupation and statin take between COPD and non-COPD subjects. After logistic regression, only age was consistent positive associated with the development of COPD.
Conclusion: Age was associated with the development of COPD.
The potential predictive value of rapid decline in FEV1 and inflammatory biomarkers for COPD need further large scale study 
